The best indicator for Analog Devices (ADI)
We backtested 20 indicators across daily, weekly and hourly charts on real Analog Devices (ADI) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Holy Grail Confluence
On the weekly chart, this is the strongest risk-adjusted edge we found for Analog Devices (ADI) over ~46.4 years — trailing buy-and-hold by 7.2% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Holy Grail Confluence ✓ | Weekly | 8.7% | 0.53 | -63.7% | 94.1% | 17 | -7.2% |
| 2 | Williams %R ✓ | Daily | 10.5% | 0.49 | -79.0% | 69.0% | 310 | -5.4% |
| 3 | Bollinger Mean-Reversion ✓ | Daily | 8.6% | 0.47 | -50.2% | 71.0% | 193 | -7.2% |
| 4 | Stochastic ✓ | Daily | 9.2% | 0.45 | -77.1% | 68.3% | 240 | -6.7% |
| 5 | EMA 50/200 Cross ✓ | Daily | 8.9% | 0.43 | -75.1% | 45.2% | 31 | -7.0% |
| 6 | CCI ✓ | Daily | 8.5% | 0.42 | -80.9% | 70.4% | 230 | -7.4% |
| 7 | WaveTrend (8/6/4) ✓ | Daily | 8.4% | 0.41 | -67.8% | 72.2% | 180 | -7.4% |
| 8 | SMA 50/200 Cross ✓ | Daily | 7.8% | 0.39 | -81.3% | 46.7% | 30 | -8.1% |
| 9 | RSI Trend (>50) ✓ | Weekly | 7.4% | 0.39 | -77.4% | 44.9% | 136 | -8.5% |
| 10 | EMA 20/50 Cross ✓ | Weekly | 7.4% | 0.38 | -88.5% | 47.6% | 21 | -8.6% |
| 11 | ADX / DMI ✓ | Weekly | 6.2% | 0.37 | -74.3% | 45.2% | 62 | -9.8% |
| 12 | Rate of Change ✓ | Weekly | 6.3% | 0.35 | -80.2% | 48.9% | 176 | -9.7% |
| 13 | RSI Mean-Reversion ✓ | Weekly | 5.3% | 0.44 | -34.1% | 100.0% | 11 | -10.6% |
| 14 | Bollinger Breakout ✓ | Weekly | 4.6% | 0.32 | -48.8% | 49.0% | 51 | -11.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Analog Devices (ADI), Holy Grail Confluence on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.